Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1CNS 1Breast 1

Conditions

Urogenital Neoplasms 1Neoplasms, Unknown Primary 1Head and Neck Neoplasms 1Digestive System Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Genetic Testing 2Filgrastim 2tipifarnib 1pembrolizumab 1etoposide phosphate 1erythromycin propionate-N-acetylcysteinate 1entinostat 1Trastuzumab 1Topotecan 1Surveys and Questionnaires 1Specimen Handling 1Quality of Life 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Oxaliplatin 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Leucovorin 1Immunotherapy 1Ifosfamide 1Genetic Counseling 1Gemcitabine 1Fluorodeoxyglucose F18 1Floxuridine 1FAPI-46 1Etoposide 1Drug Therapy 1Docetaxel 1Cyclophosphamide 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Unknown Primary × Genetic Counseling × CNS × Clear all
NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Mayo Clinic

Phase 1 Completed
230 enrolled
BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡